Innodata Inc vs BIO-TECHNE Corp — how do they compare? Innodata Inc trades at $63.27 (market cap $2.05B), while BIO-TECHNE Corp trades at $72.4 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 5.5× Innodata Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Innodata Inc pays none. Which is the better fit depends on your goals.
| INOD | TECH | |
|---|---|---|
Market Cap | $2.05B | $11.24B |
Sector | Technology | Health |
52-Week High | $121.50 | $72.29 |
52-Week Low | $34.45 | $43.31 |
Enterprise Value | $1.80B | $11.32B |
Dividend Yield | — | 0.44% |
Trailing returns across standard periods
Latest headlines on both assets
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →